Patent details
EP3957631 Title: QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA
Basic Information
- Publication number:
- EP3957631
- PCT Application Number:
- CN2020085552
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP207906462
- PCT Publication Number:
- WO2020211860
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA
- French Title of Invention:
- COMPOSÉ DE QUINOLÉINE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI POUR LE TRAITEMENT DU SARCOME D'EWING
- German Title of Invention:
- CHINOLINVERBINDUNG ODER PHARMAZEUTISCH ANNEHMBARES SALZ DAVON ZUR BEHANDLUNG DES EWING-SARKOMS
- SPC Number:
Dates
- Filing date:
- 20/04/2020
- Grant date:
- 10/09/2025
- EP Publication Date:
- 23/02/2022
- PCT Publication Date:
- 22/10/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/09/2025
- EP B1 Publication Date:
- 10/09/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 20/04/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/09/2025
- Name:
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Address:
- No. 369 Yuzhou South Rd., Lianyungang City, Jiangsu 222062, China (CN)
Inventor
1
- Name:
- ZHANG, Xiquan
- Address:
- China (CN)
2
- Name:
- XU, Jie
- Address:
- China (CN)
3
- Name:
- XU,Ping
- Address:
- China (CN)
4
- Name:
- WANG,Chengqian
- Address:
- China (CN)
5
- Name:
- ZHAN, Xiaole
- Address:
- China (CN)
6
- Name:
- TU, Lifan
- Address:
- China (CN)
7
- Name:
- YANG, Chaoqiang
- Address:
- China (CN)
8
- Name:
- WANG, Xunqiang
- Address:
- China (CN)
Priority
- Priority Number:
- 201910315417
- Priority Date:
- 19/04/2019
- Priority Country:
- China (CN)
Classification
- IPC classification:
- A61K 31/4709; A61K 31/475; A61K 31/4745; A61K 45/06; A61P 35/00; C07D 401/12;
Publication
European Patent Bulletin
- Issue number:
- 202537
- Publication date:
- 10/09/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/04/2026
- Annual Fee Number:
- 7
- Annual Fee Amount:
- 82 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|